Company / Return on Assets (ROA)
NeoGenomics Laboratories, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-7.9%
FY2025
5-year range
-8.3% / -0.4%
FY2021-FY2025
Trend
-65.1%
vs FY2024
Sector context
#125 of 159
Health Care
What the data says
NeoGenomics Laboratories, Inc.'s return on assets (roa) of -7.9% is lower than 79% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -8.3% in FY2022 to 1.1% in FY2019.
Based on SEC 10-K filings.
-7.9% in FY2025 with a 5-year CAGR of -8.4%.
Declined from -5.2% to -7.9% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +0.4pp
- 5-Year Change
- -8.4pp
- 10-Year Change
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 159This company -7.9% Sector average -2.2%
▼
-259.0% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 65.1% year-over-year.
- Currently 5.7pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2019.
- Lowest return on assets (roa) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -7.9% | -65.1% |
| FY2024 | -4.8% | +8.0% |
| FY2023 | -5.2% | +36.9% |
| FY2022 | -8.3% | -1742.2% |
| FY2021 | -0.4% | -207.1% |
| FY2020 | 0.4% | -62.8% |
| FY2019 | 1.1% | +117.3% |
| FY2018 | 0.5% | +572.7% |
| FY2017 | -0.1% | +94.0% |
| FY2016 | -1.8% | -152.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026